|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
TABUK PHARM. MANUFACTURING CO.
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Paracoccidioidomycosis |
|
Blastomycosis |
|
Candidiasis |
|
Chromomycosis |
|
Coccidioidomycosis |
|
Dandruff |
|
Dermatitis, seborrheic |
|
Histoplasmosis |
|
Tinea corporis |
|
Tinea cruris |
|
Tinea pedis |
|
Tinea versicolor |
| |
|
|
SIDE EFFECTS:
|
|
Itching, stinging, or irritation not present before therapy |
|
Contact dermatitis |
|
Dry skin |
|
dryness or oiliness of the hair and scalp |
|
Increase in normal hair loss |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
Sensitivity to topical ketoconazole |
|
|
ADULT DOSE:
|
|
Tinea corporis or
Tinea cruris or
Tinea pedis or
Pityriasis versicolor-
Topical, to the affected skin and surrounding areas, once a day.
Candidiasis, cutaneous-
Topical, to the affected skin and surrounding areas, once a day. More resistant cases may require twice a day treatment.
Seborrheic dermatitis-
Topical, to the affected skin and surrounding areas, two times a day.
[Paronychia] or
[Tinea barbae] or
[Tinea capitis] -
Topical, to the affected skin and surrounding areas, two or three times a day. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Safety and efficacy have not been established.
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|